Temporal Interference for Drug Resistant Epilepsy
RecruitingNCT06708143Phase: NAStarted 2024-11-30
Summary
This single-center prospective study aims to investigate the treatment efficacy of temporal interference (TI) in drug-resistant epilepsy patients aged 6-60.
Eligibility
Sex
ALL
Min Age
6 Years
Max Age
60 Years
Locations
Xuanwu Hospital, Capital Medical UniversityBeijing, Beijing Municipality, China
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06708143